- Home
- / CanSino Biologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CanSino Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
¥1.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1M | 18.5M | 4.3B | 1.0B | 345.2M | 824.9M | 1.1B | |
| Cost of goods sold | 13.8M | 1.2B | 1.1B | 949.7M | 30.8M | 81.4M | ||
| Gross profit | 8.7M | 15.6M | 87.6M | 3.1B | 21.8M | (479.0M) | 853.3M | 1.1B |
| Gross profit margin, % | 764.7% | 472.4% | 71.6% | 2.1% | -138.8% | 103.4% | 104.7% | |
| Operating expense total | 147.9M | 197.3M | 496.1M | 1.2B | 1.2B | 1.3B | 979.5M | 902.9M |
| Depreciation and amortization | 12.0M | 22.5M | 31.8M | 99.4M | 230.0M | 271.5M | 213.7M | 178.7M |
| EBITDA | (139.2M) | (181.7M) | (408.5M) | 1.9B | (1.2B) | (1.8B) | (143.0M) | 204.5M |
| EBITDA margin, % | -12297.0% | -2202.9% | 44.2% | -118.2% | -510.9% | -17.3% | 19.3% | |
| EBIT | (151.0M) | (203.9M) | (439.5M) | 1.8B | (1.5B) | (2.1B) | (432.4M) | 17.5M |
| EBIT margin, % | -13340.6% | -2370.2% | 41.8% | -140.8% | -601.9% | -52.4% | 1.7% | |
| Interest income | 205.0K | 21.8M | 31.7M | 79.7M | 65.9M | 100.1M | 63.9M | 34.8M |
| Interest expense | 93.0K | 140.0K | 20.7M | 41.8M | 64.3M | 60.2M | 39.9M | |
| Pre tax profit | (138.3M) | (156.8M) | (396.6M) | 1.9B | (1.2B) | (2.0B) | (381.2M) | 21.7M |
| Income tax expense | 29.7M | (219.2M) | (11.5M) | 2.5M | (6.1M) | |||
| Net Income | (138.3M) | (156.8M) | (396.6M) | 1.9B | (964.8M) | (2.0B) | (383.7M) | 27.9M |